Related Experiment Video
Updated: Nov 9, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
Buschke-Lowenstein Tumors: A Review and Proposed Classification System
Kurt G Davis1, Jeffrey S Barton1, Guy Orangio1
1From the Departments of Surgery.
Buschke-Lowenstein (B-L) tumors, caused by human papillomavirus (HPV), are distinct from verrucous carcinoma and do not have high mortality or malignancy rates. This review provides a definition and grading system for these anogenital lesions.
Area of Science:
- Dermatology
- Oncology
- Infectious Diseases
Background:
- Buschke-Lowenstein (B-L) tumors, also known as giant condylomata, are rare anogenital lesions.
- These lesions are caused by human papillomavirus (HPV).
- Current literature lacks a standardized definition and contains misconceptions regarding B-L tumors.
Purpose of the Study:
- To review the existing literature on Buschke-Lowenstein tumors.
- To establish a workable definition for B-L tumors.
- To clarify misconceptions about their mortality, malignancy rates, and relationship to verrucous carcinoma.
Main Methods:
- Comprehensive literature search of PubMed and Embase databases from 1925 to 2020.
- Evaluation of clinical data, including presentation and treatment from published reports.
- Analysis of definitions and case reports to address misconceptions.
Main Results:
- No accepted definition for B-L tumors was found; an inclusive definition is proposed.
- Contrary to common belief, B-L tumors do not exhibit high mortality or malignancy rates.
- B-L tumors are distinct from verrucous carcinoma, despite shared HPV etiology.
Conclusions:
- Buschke-Lowenstein tumors are HPV-associated anogenital lesions distinct from verrucous carcinoma.
- A proposed definition and grading system aim to aid future study and management.
- Further research is needed to clarify specific HPV type associations and optimal treatment strategies.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019